✦ LIBER ✦

Cost-effectiveness Analysis of the National Perinatal Hepatitis B Prevention Program

✍ Scribed by Barbosa, C.; Smith, E. A.; Hoerger, T. J.; Fenlon, N.; Schillie, S. F.; Bradley, C.; Murphy, T. V.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Cost-Effectiveness Analysis of a Propo

✍ Wu, Shinyi; Keeler, Emmett B.; Rubenstein, Laurence Z.; Maglione, Margaret A.; S 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 235 KB

Antenatal lamivudine to reduce perinatal

✍ Nayeri, Unzila A.; Werner, Erika F.; Han, Christina S.; Pettker, Christian M.; F 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 272 KB

Cost-effectiveness analysis of hepatitis

✍ Guy Tormans; Pierre Van Damme; Eddy Van Doorslaer 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 509 KB

Preventing the perinatal spread of hepat

✍ Brady, Margaret 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 437 KB

Cost–benefit analysis of the Polish hepa

✍ Danuta Wiewióra-Pilecka 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 74 KB

The cost-effectiveness of hepatitis B va

✍ J.L. Dienstag; M.D. Silverstein; A.G. Mulley 📂 Article 📅 1983 🏛 Elsevier Science 🌐 English ⚖ 243 KB